BC
DGX icon

Broadfin Capital’s Quest Diagnostics DGX Stock Holding History

Broadfin Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,000
Closed -$1.54M – 62
2013
Q3 		$1.54M Buy
+25,000
New +$1.5M 0.27% 54

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Broadfin Capital's DGX Position: Q4 2013 in Review

Broadfin Capital sold out of Quest Diagnostics (DGX) in Q4 2013, closing a stake of 25,000 shares — an estimated $1.54M sold.

Broadfin Capital first reported a position in DGX in Q3 2013 and held it in 1 quarter. The position peaked at $1.54M in Q3 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • Broadfin Capital reported no remaining Quest Diagnostics position as of Q4 2013 after selling out during the quarter.
  • Broadfin Capital sold 25,000 Quest Diagnostics shares in Q4 2013, an estimated $1.54M.
  • Broadfin Capital first reported a position in Quest Diagnostics in Q3 2013 and held it in 1 quarter.
  • Broadfin Capital's Quest Diagnostics position peaked at $1.54M in Q3 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Broadfin Capital's 13F filing for Q4 2013, filed 14 Feb 2014.